The ZERO Prostate Cancer Summit is the premier annual prostate cancer event, offering the support, education, networking, and advocacy opportunities to empower those affected by the disease. Sign up today to be a part of this important event and a member of our inspiring community.
2023
PROGRAM FEBRUARY 26-28, 2023
Gaylord National Resort and Convention Center National Harbor, MD
Thank You to Our Sponsors for Making the ZERO Summit Possible!
PREMIER SPONSOR:
CAREGIVER SPONSOR:
PLATINUM SPONSORS:
GOLD SPONSORS:
SILVER SPONSORS:
BRONZE SPONSORS:
Exelixis
PhRMA
Genentech
Intuitive Surgical
Biotechnology Innovation Organization
2 #ZEROSummit2023
Dear ZERO Summit Attendees,
I’m thrilled to welcome you to the 2023 ZERO Prostate Cancer Summit! What started in 1996 as the March on Washington to establish direction and expansion of prostate cancer research funding now has become the premier, annual event to educate, support, and activate an ever-expanding prostate cancer community. If this is your first Summit with us, we welcome you with open arms and know you’ll find a home among the cause champions around you. Together, we strive to make sure no one faces prostate cancer alone. Year after year, our Summit is one of my favorite events. Attendees come away with new knowledge, lifelong friendships, and passion and purpose for the cause. The Summit gives you the opportunity to learn, grow, connect, and inspire. Below are some of this year’s Summit highlights you won’t want to miss. On Sunday, help us celebrate the inspiring and remarkable ZERO Champions and partners who have gone above and beyond in their support of the prostate cancer community at the Bold for Blue Awards. This special event will also be livestreamed for our virtual audience to join us. On Monday, I’ll share some exciting ZERO news, and then we’ll learn the latest on prostate cancer topics from the leading experts in the field. Topics will include emerging technologies in prostate cancer, disease misinformation, treatment updates, clinical trials, establishing health equity, achieving sexual health, side effect mitigation, advances in genetics and genomics, and much more. On Tuesday, a well-trained, ready, and primed group of advocates will attend Capitol Hill meetings in an effort to advance prostate cancer research and access to care. The rest of our Summit attendees will have access to educational sessions covering a variety of
topics, including how to manage health insurance and finances while facing cancer, the impacts of fitness, PSMA and the imaging landscape, facing emotional side effects, and resources for caregivers. The Summit is a place of togetherness and belonging. It is where you see old friends and quickly make
new ones. It is where leaders emerge and shine to help us get one step closer to ZERO Prostate Cancer. I’m delighted to have you as part of our community of changemakers and leaders tirelessly working to improve the lives of all those affected by prostate cancer. As I conclude my 21-year tenure at ZERO this summer, it has been the honor of a lifetime to serve you and the prostate cancer community. Along the way, there have been countless stories and people who have inspired me. I hold all of them close to my heart. Now that we’re back in person, I can’t wait to connect with you and make some new memories together. Thank you for joining our community and shared cause. Together, we are an unstoppable force. With gratitude,
Jamie Bearse President and CEO @jamiebearse
ZEROCANCER.ORG/SUMMIT 3
SCHEDULE
Sunday, February 26 The Bold for Blue Awards Ceremony kicks-off the 2023 ZERO Prostate Cancer Summit! All Are Welcome to Attend
Bold for Blue Reception Cherry Blossom Ballroom
7:00 p.m. - 8:00 p.m.
Bold for Blue Award Ceremony Cherry Blossom Ballroom
8:00 p.m. - 9:00 p.m.
Sponsored by:
4 #ZEROSummit2023
AGENDA Monday, February 27 Education, advocacy training, and support lounge sessions are available throughout today.
8:45 a.m. - 8:55 a.m. Welcome and Opening Remarks Ali Manson, ZERO, and Shelby Moneer, ZERO 8:55 a.m. – 9:00 a.m. Welcome from Premier Sponsor Pfizer 9:00 a.m. - 9:05 a.m. Welcome from ZERO’s Board of Directors Tom Bognnano,
10:30 a.m. - 11:00 a.m. Emerging Technologies in Prostate Cancer Nilay Gandhi, MD 11:00 a.m. - 11:15 a.m. Break 11:15 a.m. - 12:00 p.m. Prostate Cancer in Your Community (Moderated by Jamie Bearse, CEO, ZERO) Alicia Morgans, MD, MPH, Charles (Chuck) J. Ryan, MD, and William (Bill) L. Dahut, MD 12:00 p.m. - 1:00 p.m. Lunch is Provided 1:00 p.m. - 1:45 p.m. Federal Prostate Cancer Research Update Melissa Cunningham, PhD 1:45 p.m. - 2:15 p.m. Break (and Advocacy Training Begins) 2:15 p.m. - 3:00 p.m. Clinical Trial Diversity & Access Elisabeth Heath, MD, FACP 3:00 p.m. - 3:45 p.m. Treatment Updates for Advanced Prostate Cancer Alicia Morgans, MD, MPH 3:45 p.m. - 4:25 p.m. Coping with the Stress of a Cancer Diagnosis Alison Mayer Sachs, MSW, LSW, OSW-C, FAOSW 4:25 p.m. - 5:00 p.m. Radiation & Side Effect Mitigation Eric Shinohara, MD, MSCI 5:00 p.m. - 7:00 p.m. Dinner Break
ZERO Board Chairman 9:05 a.m. – 9:45 a.m. Keynote Address Jamie Bearse, ZERO CEO 9:45 a.m. – 10:00 a.m.
Mission Speaker James Williams, Jr.
Thank You to Our Premier Sponsor:
(Meal Not Provided) 7:00 p.m. - 8:30 p.m. Dessert and Sexual Health Panel Discussion: Ask Anything! Rachel Rubin, MD, and Patrick Wenning, PT, MPT, CIMPT, CMTPT ZEROCANCER.ORG/SUMMIT 5
Please note that agenda items are subject to change.
SUPPORT GROUPS
Monday, February 27 In-Person Support Groups
Advanced Stage Disease
10:00 a.m. - 11:00 a.m. 10:00 a.m. - 11:00 a.m. 1:00 p.m. - 2:00 p.m. 2:00 p.m. - 3:00 p.m.
Female Caregivers
Recurrence
Active Surveillance
Virtual Support Groups
Active Surveillance
10:00 a.m. - 11:00 a.m. 11:00 a.m. - 12:00 p.m.
High Risk, Recurrent and Advanced Stage Disease
LGBTQIA+ Community 60 or Under with Prostate Cancer? This Group is for You!
12:15 p.m. - 1:15 p.m. 2:00 p.m. - 3:00 p.m.
Why Patient Preferences are Important for Deciding on Treatment Help Navigating Urinary Incontinence Post Treatment
3:00 p.m. - 4:00 p.m.
4:00 p.m. - 5:00 p.m.
Newly Diagnosed, Partners Welcome!
6:00 p.m. - 7:00 p.m.
Erectile Dysfunction Post Treatment and Intimacy - What Every Couple Should Know
7:00 p.m. - 8:00 p.m.
Virtual Support Groups Available Through the Summit App Or Visit: zerocancersummit.us.chime.live
Please note that agenda items are subject to change.
6 #ZEROSummit2023
AGENDA Tuesday, February 28
ZERO’s Advocates will attend scheduled meetings on Capitol Hill beginning at 8:30 a.m. today, while others join the education sessions.
7:00 a.m. - 8:30 a.m. Breakfast is Provided 8:30 a.m. - 9:15 a.m. Genetics & Genomics of Prostate Cancer with Channing Paller, MD 9:15 a.m. - 10:00 a.m. PSMA PET and the Imaging Landscape with Mike Smith, BSPS, CNMT 10:00 a.m. - 10:30 a.m. Break 10:30 a.m. - 11:15 a.m. Re-Irradiation of the Prostate for Cure Using the MRIdian Linear Accelerator: Getting to YES with Michael Greenberg, MD 11:15 a.m. - 12:00 p.m. Physical and Emotional Side Effects of Prostate Cancer with Meredith Morgan, MSN, NP 12:00 p.m. - 1:00 p.m. Lunch is Provided
1:00 p.m. - 1:45 p.m. Health Insurance & Finances with Joanna Morales, Esq. 1:45 p.m. - 2:30 p.m. Caring for the Caregiver: It’s A Marathon, Not a Sprint with Alison Mayer Sachs, MSW, LSW, OSW-C, FAOSW 2:30 p.m. - 3:15 p.m.
How Fitness Impacts Prostate Cancer with Jen Miramontes, CES, MES, CPT 3:15 p.m. - 3:30 p.m. Closing Remarks with Shelby Moneer, ZERO 5:30 p.m. - 7:30 p.m. Congressional Reception on Capitol Hill Hill Advocates ONLY
Please note that agenda items are subject to change.
ZEROCANCER.ORG/SUMMIT 7
Thanks to Our Summit Ambassadors! Thank you to our Summit Ambassador volunteer leaders who are here to make your Summit experience and time with ZERO great by welcoming you, answering questions, and assisting you, as needed. You can find these volunteers by their “How Can I Help You?” and Summit Ambassador badg- es. Anything you need, they will be happy to help! Tammy Holbert* Mike Rotz* Vivian Avery Keisha Hampton-Williams Brian Jones
Joe Musumeci Cheryl Nikituk Tara Nikituk Sharon Rose
Educational Videos on Demand
Susie Schlernitzauer Venetia Wilhelmsen CC Williams Don Williamson *Co-Chairs
In addition to all the support and education you will experience in person at the Summit, you have video on demand available to you. The videos will remain active, and you can also access them after the event is over.
Topics Include: Pathology of Prostate Cancer
SpaceOAR for Radiation Therapy Evan Goldfischer, MD, MBA, FACS, Sponsored by Boston Scientific Let’s Make It Clear: PSMA/PET Imaging for Prostate Cancer Daneil Kuftinec, MD, Sponsored by Lantheus Racial Disparities in Prostate Cancer Kelvin Moses, MD, PhD Clinical Trials Hala Borno, MD Place-based Disparities Mindy Herbert DeRouen, PhD, MPH Cancer and Cardiovascular Disease Avirup Guha, MD, MPH, RPVI, FICOS, FACC
Tamara Levin Lotan, MD Sexual Minorities and Prostate Cancer Marvin Langston, PhD
Check the ZERO Summit App for More Information
So You Want to Be an Advocate! Ali Manson, MPH - ZERO, Jonelle Flowers, Activation - Pfizer, and Stacy Reliford, Alliance Development - Pfizer, Sponsored by Pfizer Oncology Management of Erectile Dysfunction (ED) and Incontinence James Furr, MD, Sponsored by Boston Scientific
Or Visit: zerocancersummit.us.chime.live
8 #ZEROSummit2023
Thank You to Our Expert Speakers:
2023
JAMIE BEARSE President and CEO, ZERO Prostate Cancer. A nonprofit leader and prostate cancer patient advocate for over 20 years, Jamie Bearse is ZERO’s President and CEO. Since taking on the role in 2013, he has led ZERO to quadruple in size while growing the ZERO Prostate Cancer Run/Walk, initiating its chapter structure, and launching ZERO360, a comprehensive patient support program. With Bearse at the helm, ZERO also increased prostate cancer research funding from $80M to $110M at the Congressionally Medical Research Programs at the DOD, raised more than $100M for patient programs and support, and successfully merged ZERO with Us TOO to create the largest prostate cancer support network in the U.S. A thought-leader in nonprofit management, organizational culture, and health advocacy, Bearse has transformed ZERO into a four-out-of-four star rated organization by Charity Navigator and one of the 50 best nonprofits to work for by the NonProfit Times in eight out of the last nine years.
TOM BOGNANNO Board Chairman, ZERO Prostate Cancer. Thomas Bognanno, President and CEO of CHC: Creating Healthier Communities, is a prostate cancer survivor with advanced disease. Bognanno is the catalyst for bringing CHC to the next level with innovative programs that focus on health disparities, community health development, employee engagement, workplace giving campaigns, and health resources. In his role he utilized his decades of experience and expertise to define strategic direction and increase income for CHC member organizations. Prior to his time with CHC, Tom spent two decades with the American Diabetes Association, and before that, with the American Cancer Society. MELISSA CUNNINGHAM, PHD Program Manager, Department of Defense, Congressionally Directed Medical Research Programs (CDMRP). Dr. Melissa Cunningham represents the Department of Defense’s Congressionally Directed Medical Research Programs (CDMRP), a funding organization whose mission is to foster novel approaches to biomedical research in response to the expressed needs of the American public, the military, and Congress. There are currently seven individual programs at CDMRP that fund urology research, including the Prostate Cancer Research Program (PCRP) that Dr. Cunningham manages. During her time at CDMRP, Dr. Cunningham has coordinated and managed a large portfolio of active research projects for the PCRP, including high-profile Prostate Cancer Clinical Trials Consortium (PCCTC). Dr.
Cunningham assumed the leadership of the PCRP as Program Manager in 2014, and is responsible for executing the entire PCRP program life cycle, including investment strategy, program announcement development, proposal review, funding of awards, and analysis of PCRP accomplishments and effectiveness. The PCRP has supported more than 3,200 prostate cancer-focused research projects, which prioritize research, high impact studies, the development of young investigators, and resources to support the prostate cancer research community.
ZEROCANCER.ORG/SUMMIT 9
NILAY M. GANDHI, MD Surgeon and Urologist, Potomac Urology, Inova Alexandria Hospital. Dr. Nilay Gandhi is a surgeon and urologist at Potomac Urology in Alexandria, VA. He is also the Vice Chair of the Department of Surgery at Inova Alexandria Hospital and the co-founder of Doctomize, a physician’s electronic medical record consulting firm. He trained at the Brady Urological Institute at Johns Hopkins Hospital, where he developed his skills alongside many pioneers in the field. In addition to his myriad of published works, Dr. Gandhi also spoke about the importance of PSA testing and early detection at a United States Preventive Services Task Force briefing on Capitol Hill in 2018. He believes that a physician is not only a medical professional but a patient’s best advocate. Dr. Gandhi also serves as the Race Director of the ZERO Prostate Cancer Run/Walk in the Capital Area.
MICHAEL GREENBERG, MD Vice Chair for Business Development and Clinical Associate Professor of Radiation Oncology, Sidney Kimmel Cancer Center and Bodine Cancer Treatment Center. Prior to his current role as Vice Chair for Business Development and Associate Professor of Radiation Oncology, Dr. Greenberg served as the Medical Director at Deleware Valley Cancer Center, New Jersey Urology. Dr. Greenberg is part of Myriad Genetics’ Advisory Board working with the urology team for implementation of biomarkers in treatment of prostate cancer. Dr. Greenberg has been working with Boston Scientific on their SpaceOAR Program and is also on the Advisory Board for Decipher Biosciences where he is working on genomics in the setting of biochemical recurrence after a prostatectomy. Dr. Greenberg attended Mount Sinai School of Medicine where he received his Doctor of Medicine and completed his residency program in radiation oncology at Harvard Medical School.
ELISABETH HEATH, MD, FACP Chair, Genitourinary Oncology Multi- disciplinary Team Barbara Ann Karmanos Cancer Institute. Dr. Elisabeth Heath is the Patricia C. and E. Jan Hartmann endowed chair in Prostate Cancer Research at the Barbara Ann Karmanos Cancer Institute and professor of Oncology and Medicine at Wayne State University School of Medicine in Detroit, Michigan. Dr. Heath has more than 26 years of experience and is a leading patient advocate for the metro Detroit community. At the ZERO Prostate Cancer Summit, she spoke about funding clinical trials and how that translates into better care for prostate cancer patients. STACY LOEB, MD Urologist, NYU Langone Health. Dr. Stacy Loeb is a Professor of Urology and Population Health at New York University (NYU) and the Manhattan Veterans Affairs Medical Center, specializing in prostate cancer. Dr. Loeb currently has grants from the Prostate Cancer Foundation, Department of Defense, and NYU Perlmutter Cancer Center. Dr. Loeb has published more than 300 peer-reviewed articles and 10 book chapters, primarily on prostate cancer, men’s health, and social media. She is on the Editorial Board for the British Journal of Urology International, Journal of Clinical Oncology, European Urology, Reviews in Urology, Nature Reviews in Urology, and Urology Times. She also authored the chapter on Early Detection, Diagnosis, and Staging of Prostate Cancer for Campbell-Walsh Urology, the primary textbook in the field. Dr.
Loeb hosts the Men’s Health Show on Sirius XM 110 US/Canadian satellite radio on Wednesdays from 6:00 p.m. - 8:00 p.m. Eastern Time. Dr. Loeb is Chair of the American Urological Association Social Media Work Group, and a member of the European Association of Urology Guidelines Office Social Media Committee.
10 #ZEROSummit2023
ALI MANSON, MPH Vice President of Government Relations and Advocacy, ZERO Prostate Cancer. Ali Manson is an experienced government relations professional with expertise in health policy, and has a passion for health and wellness. In Ali’s previous role at the American Optometric Association (AOA), she took the concerns of eye doctors and patients to policymakers to demand change. She will be such an amazing asset as we storm the hill to fight for prostate cancer research funding and new treatments. For Ali, there is nothing more rewarding than working with and for a nonprofit to achieve a meaningful mission. Prior to AOA, she worked for Prevent Blindness as the Director of Government Affairs, leading policy efforts to improve vision health across the country. She’s also worked for the National Coalition on Health Care, where she developed
strategies to make the American health system more sustainable, affordable, and fair. She earned an advanced degree in public health from George Washington University and received her undergraduate education at the University of Virginia.
JEN MIRAMONTES, CES, MES, CPT Founder, Cancer Champions. Compassionate, experienced, and highly educated, Jen Miramontes has become one of the leading experts on fitness and cancer. She is the founder of Cancer Champions, an online fitness and nutrition program for cancer fighters and survivors. Miramontes has been involved in sports and fitness her entire life and for the past twelve years she has worked as a coach, personal trainer, teacher, and one of only about 500 certified cancer exercise specialists in the world. There is no health issue more personal to Miramontes than that of cancer. Having lost several loved ones to cancer, Miramontes is committed to making a difference for those fighting this awful illness. She has spent many years working with individuals battling cancer. From workshops to seminars, participants will
walk away with the latest research, new ideas, and renewed hope. Fighting cancer involves so much more than radiation and chemotherapy. Fitness and nutrition can help improve mood, energy, and overall well-being, and are vital aspects of the battle against cancer.
SHELBY MONEER Vice President of Patient Programs and Education, ZERO Prostate Cancer. Shelby Moneer leads ZERO’s comprehensive suite of patient support programs. She is an experienced educator and health professional. After earning an advanced degree in health education, she developed educational programs ranging from tobacco cessation to exercise physiology for various nonprofits. Most recently, she was the Director of Education at the Melanoma Research Foundation, where she exercised her passion for supporting and educating cancer patients. She is excited to continue her educational and programmatic work with and for the prostate cancer community.
ZEROCANCER.ORG/SUMMIT 11
JOANNA FAWZY MORALES, ESQ. CEO, Triage Cancer. Joanna Morales is a cancer rights attorney, author, speaker, and CEO of Triage Cancer, a national, nonprofit organization providing free education on practical and legal issues that may impact individuals coping with cancer and their caregivers, through events, materials, and resources. Morales has spent nearly 30 years working on behalf of individuals with cancer, including five as an Adjunct Professor of Law at Loyola Law School, teaching a seminar in Cancer Rights Law, and eight at the John Wayne Cancer Institute’s Psychosocial Care Program and Positive Appearance Center. She has also taught a Community Advocacy Clinic, as an Adjunct Professor of Law at Wayne State University Law School. Morales co-authored the book, Cancer Rights Law, for the American Bar Association – the first
and only book of its kind. In 2020, she wrote a chapter titled Cancer-Related Legal Issues, for the Oncology Nursing Society’s book, Oncology Nurse Navigation: Delivering Patient-Centered Care Across the Continuum. In 2017, she wrote Preventing or Minimizing Financial Toxicity Across the Continuum of Cancer Care, a chapter for the Oncology Nursing Society’s book, Cancer Survivorship: Transdisciplinary, Patient-Centered Approaches to the Season of Survival. In 2009, she also contributed to a book entitled Work and Cancer Survivors. And, her work has appeared in a variety of other publications. In addition, she has served on numerous cancer community committees and boards: as Chair of the Board of Directors for the California Division of the American Cancer Society, ZERO Prostate Cancer’s Medical Advisory Board, the National Advisory Board of CancerForward, the Stupid Cancer Survivorship Advisory Council, and the Executive Committee of the American Bar Association’s Breast Cancer Task Force. MEREDITH MORGAN, NP, MSN, ACNP-BC Nurse Practitioner, Rogel Cancer Center, University of Michigan. Meredith Morgan is a board-certified acute care nurse practitioner currently working in the Urologic Oncology Clinic at the Rogel Cancer Center in Ann Arbor. She is also an adjunct faculty clinical instructor at the University of Michigan School of Nursing. Morgan leads lectures on prostate cancer for new oncology nurses at the University of Michigan and regularly precepts nurse practitioner students. Her current practice includes prostate cancer survivorship and advanced prostate cancer. She is also active in prostate cancer clinical trials. She has previously worked with prostate cancer patients at Vanderbilt University Medical Center and Weill Cornell Medical College/New York-Presbyterian Hospital. She is a member of the American Urological Association, Oncology Nursing Society, Society of Urologic Nurses and Associates, and the Michigan Council of Nurse Practitioners.
ALICIA MORGANS, MD, MPH Medical Director - Survivorship Program, Dana-Farber Cancer Institute. Dr. Alicia Morgans is a Genitourinary Medical Oncologist and the Medical Director of the Survivorship Program at Dana-Farber Cancer Institute in Boston, Massachusetts. She specializes in investigating complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications, and in investigating and incorporating shared decision making into the treatment process for men with advanced prostate cancer. She also serves as the Principal Investigator for multiple prostate cancer clinical trials, including the ECOG Phase 3 ERADICATE trial. She is a member of the advanced and localized prostate cancer treatment guidelines committees of the American Urologic Association,
and is a member of the cardio-oncology committee of American Heart Association. Dr. Morgans’ research focus is on improving care and patient outcomes in advanced prostate cancer. Her research investigates the side effects of cancer treatment (including the prevention, diagnosis of, and treatment of these effects) and treatment decision- making among men with advanced prostate cancer. She also has an interest in supporting clinical research of novel treatments for genitourinary malignancies. Dr. Morgans is a member of the American Society of Clinical Oncology and the Eastern Cooperative Oncology Group. She also serves as Vice Chair of ZERO’s Board of Directors. Dr. Morgans has contributed to numerous educational resources on behalf of ZERO.
12 #ZEROSummit2023
CHANNING PALLER, MD Professor of Oncology & Urology at Johns Hopkins University. Dr. Channing Paller is associate professor of Oncology and Urology at Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, and associate director for Oncology of the Johns Hopkins Clinical Research Network. She is a clinician scientist focused on translating basic scientific findings into treatments that will improve clinical outcomes and reduce toxicities for men with prostate cancer. Dr. Paller is a lead investigator of the PROMISE registry and, as an expert in clinical trial design, she leads multiple clinical trials of innovative new treatments and treatment combinations employing germline and somatic biomarkers. She earned her MD at Harvard Medical School and completed her medical residency and fellowship in Medical Oncology at Johns Hopkins. RACHEL S. RUBIN, MD Urologist and Sexual Medicine Specialist, Assistant Clinical Professor in Urology, Georgetown University Hospital. Dr. Rachel S. Rubin is a board-certified urologist with fellowship training in sexual medicine. She is an assistant clinical professor in urology at Georgetown University and owns her own practice in Washington D.C. Dr. Rubin provides comprehensive care to men and women. She treats issues such as pelvic pain, menopause, erectile dysfunction, and low libido. Dr. Rubin is currently the education chair for the International Society for the Study of Women’s Sexual Health (ISSWSH) and an associate editor for the journal Sexual Medicine Reviews. She was named a Washingtonian Top Doctor from 2019 to 2022 and has been on the ZERO Medical Advisory Board since 2018. CHARLES (CHUCK) J. RYAN, MD President and Chief Executive Officer, Prostate Cancer Foundation. Dr. Charles J. Ryan is an internationally recognized genitourinary (GU) oncologist with expertise in the biology and treatment of advanced disease as well as the supportive care of all men with prostate cancer. He was most recently the Director of the Hematology, Oncology and Transplantation Division in the Department of Medicine at the University of Minnesota, Minneapolis. He also served as the Associate Director for Clinical Research in the Masonic Cancer Center and held the B.J. Kennedy Chair in Clinical Medical Oncology. He has published over 200 articles and chapters in the world’s leading medical journals. He is the author of the book The Virility Paradox: The Vast Influence of Testosterone on Our Bodies, Minds, and the World We
Live In, released in February 2018. Dr. Ryan is also the Leader of the Advanced Prostate Cancer Cadre in the Alliance for Clinical Trials in Oncology, a national clinical trials group, and past Chair of the NCI GU Steering Committee’s Prostate Cancer Task Force.
ALISON MAYER SACHS, MSW, CSW, OSW-C Director of Community Outreach and Cancer Support Services, Eisenhower Lucy Curci Cancer Center. Recognized nationally for her leadership in the field of Oncology Social Work, Alison Mayer Sachs is the chair of the Southern California Division of the American Cancer Society, and sits on the Scientific Advisory Board of the Go2Foundation for Lung Cancer; the Medical Advisory Board of ZERO - The End of Prostate Cancer; and Chairs the Patient Assistance Committee of the Desert Cancer Foundation. As the Director of Community Outreach and Cancer Support Services, Mayer Sachs and her team are responsible for the development, design, and implementation of community outreach events, community education programs, oncology social work services, oncology nurse
navigation services and disease prevention and health promotion programs at Eisenhower’s Lucy Curci Cancer Center. Maintaining direct patient care, Mayer Sachs facilitates Lucy Curci Cancer Center’s Breast Cancer, Prostate Cancer and Multiple Myeloma and Blood Cancer Information and Support Groups. Working alongside the Cancer Center’s CAO, she works with Eisenhower’s Foundation Office cultivating donor relations, and assists Eisenhower’s PR/Marketing Department in identifying and maximizing opportunities to highlight the cancer center’s programs and accomplishments to a wide and varied audience locally, state-wide, and nationally. ZEROCANCER.ORG/SUMMIT 13
ERIC SHINOHARA, MD, MSCI Ingram Associate Professor and Chair, Vanderbilt University. Dr. Eric Shinohara is a board-certified radiation oncologist, Associate Professor, and Clinical Chair of the Department of Radiation Oncology at Vanderbilt University Medical Center. He received his B.S. in Physiology and Neurobiology from the University of Maryland, then continued his medical education as a graduate of Vanderbilt’s School of Medicine. He completed his medical internship at Abington Memorial Hospital followed by a residency at the University of Pennsylvania. Dr. Shinohara’s clinical and research areas of interest are in tumors of the genitourinary system and sarcomas. He has presented at several international meetings, such as the American Society for Radiation Oncology (ASTRO), and has been published in many prominent journals, including Cancer, Cancer Research, and Oncogene. MIKE SMITH, BSPS, CNMT Senior Medical Imaging Specialist, Blue Earth Diagnostics. Mike Smith is the Senior Medical Imaging Specialist for Blue Earth Diagnostics that covers the Great Lakes, Northeast, and Mid-Atlantic regions. He has 12 years of clinical nuclear medicine experience, previously working at Ohio State, and rotating between general, cardiac, and PET. In his current role of almost years, he has helped with educating both readers and technologists about how to properly image and interpret Axumin, collaborated on Real-World Evidence and Investigator Initiated Trials, and assisted on multiple Company Sponsored Phase 1-3 trials aimed at expanding indications and researching new radiopharmaceuticals. PATRICK WENNING, PT, MPT, CIMPT, CMTPT Physical Therapist, Restore Motion. Patrick Wenning joined Restore Motion in the D.C. Metro area in 2016 after owning his own private practice in Manhattan for over 10 years. In addition to his general orthopedic practice, he worked with dancers and actors of all levels from amateur to Broadway in New York. His focus is with patients who have spine, pelvic and foot/ankle issues. He primarily works as a manual therapist and has specialties in Men’s Pelvic Floor, foot orthotic casting and Performing Arts rehab. He has certification as an Integrated Manual Therapist and in Manual Trigger Point Dry Needling from Myopain Seminars and works with alternative modalities as diverse as craniosacral, pilates, and visceral mobilization. His background is in theater, dance, and gymnastics. Patrick earned his Master of Physical Therapy degree from Hardin-Simmons University in Abilene, Texas in 1998. JAMES M. WILLIAMS, JR. Director of Federal Affairs for Cancer Prevention, Early Detection and Screening, American Cancer Society Cancer Action Network. A native Washingtonian, James M. Williams, Jr., is a two-time prostate cancer survivor turned passionate warrior in the fight against cancer. After years of Capitol Hill and government relations experience, James joined the American Cancer Society-Cancer Action Network as the director of federal affairs for cancer prevention, early detection and screening. Hear from James about how he turned his personal experiences into a career advocating to ensure that others can enjoy the same kind of future that he has - one filled with service, love, and family. James will pump you up to make the most of your time learning, connecting, and advocating with the ZERO family.
SHARE YOUR PHOTOS from the ZERO Summit on social media using #ZEROSummit2023
14 #ZEROSummit2023
You Can Help Patients in Need: Make Sure No One Fights Alone
Introducing the Jamie Bearse Patient Emergency Fund
With prostate cancer cases projected to increase again this year, the need for your help is greater than ever. In the past 12 months, the demand for ZERO’s support services to help patients and their families has more than doubled. It is unacceptable that so many patients in need are falling through the cracks because of financial barriers to the life- saving care they deserve. To address the growing needs of patients and families, ZERO is establishing the Jamie Bearse Patient Emergency Fund to directly fund patient support programs like ZERO360. In celebration of ZERO President and CEO Jamie Bearse’s leadership and the significant progress he has led to support patients and families, this new fund will provide prostate cancer patients in desperate need with critical, life-saving support. One of the beneficiaries of ZERO360 is ZERO Champion, Ted Healy. When Ted was diagnosed with advanced prostate cancer, he was facing a heartbreaking choice: expensive treatments that would extend his life or financial ruin. ZERO360, a comprehensive patient support program, was there to answer his call.
TED HEALY ZERO Champion
“My prostate cancer diagnosis was terrifying. Just as scary was the decision between life-saving treatments and financial stability. Thanks to ZERO360 and donors like you, I didn’t have to choose.”
Your support of this fund will be dedicated to: • Providing personalized assistance in managing the practical and personal challenges of prostate cancer. These services include financial aid, insurance navigation, emotional support, benefit enrollment, and more. • Bridging the gap between racial and health disparities in prostate cancer. Where you live, the color of your skin, or the size of your paycheck shouldn’t determine whether you get quality care in a cancer crisis. No patient should choose between financial ruin and life-saving treatments and support. When you support the Jamie Bearse Patient Emergency Fund, you help ensure patients in need are not alone.
Donate to help patients through the Jamie Bearse Patient Emergency Fund:
zerocancer.org/emergency
ZEROCANCER.ORG/SUMMIT 15
Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16Made with FlippingBook flipbook maker